[Ip-health] Cover Story in Frontline Magazine: Patent to Plunder

Shailly Gupta shailly.gupta at geneva.msf.org
Tue Apr 17 23:30:01 PDT 2012


Series of articles on Novartis Case against Government of India challenging
section 3(d) of patent law and recently issued Compulsory License to a
generic company in India.

Patent to plunder
AMIT SENGUPTA
India's efforts to produce and supply life-saving drugs at affordable prices
face challenges from multinational companies trying to "evergreen" their
patents.
http://www.frontline.in/stories/20120504290800400.htm 

A big step forward
C.P. CHANDRASEKHAR
That this is the first time a compulsory licence has been granted in India
is in itself important.
http://www.frontline.in/stories/20120504290801000.htm 

Patents and the law
V. VENKATESAN
The implementation of Patents Act, as last amended in 2005, raises
significant issues of immediate concern to patients across the world.
http://www.frontline.in/stories/20120504290801300.htm 

Drug and duplicity
Brook Baker
NOVARTIS has long been suing the Government of India to eliminate or weaken
Section 3(d) of the Patents (Amendment) Act, 2005, which established strict
standards of patentability in order to prevent the ever-greening of patent
monopolies on medicines.
http://www.frontline.in/stories/20120504290802800.htm 

A welcome first
T.K. RAJALAKSHMI
Industry reacts with caution to the grant of a compulsory licence to Natco,
but cancer patients welcome it and hope for many more.
http://www.frontline.in/stories/20120504290801600.htm 

Western warnings
R. RAMACHANDRAN
India is coming under increasing pressure from the U.S. and the European
Union for the strict patentability criteria it applies for medicines.
http://www.frontline.in/stories/20120504290801800.htm

Question of efficacy
LEENA MENGHANEY
The country is clearly shaping its legislation to promote access to
medicines by fostering generic production.
http://www.frontline.in/stories/20120504290802200.htm 

'The current patent system is deeply flawed'
V. VENKATESAN
Interview with Shamnad Basheer, Intellectual Property Law Professor at NUJS.
http://www.frontline.in/stories/20120504290802600.htm 


----------------------------------------------------------------------------
-------
Regards

Shailly Gupta
Policy Advocacy Officer
Medecins Sans Frontieres
Access Campaign
C 236 Defence Colony 
New Delhi, India
Tel: +91 11 46573730-31
M: 9899976108







More information about the Ip-health mailing list